Fieldview Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,294
Closed -$349K 560
2024
Q4
$349K Buy
+8,294
New +$349K 0.05% 332